Action Technology’s rubber compounding expertise enables FDA compliance, unlocks new market segment for stopper manufacturer

Challenge:

A European manufacturer of rubber stoppers for parenteral pharmaceutical applications was interested in expanding its business. However, its existing compounder could not deliver materials that would meet Food & Drug Administration (FDA) guidelines, or meet stringent new purity, color and appearance requirements. These shortcomings resulted in productivity loss and inability to grow the business into new applications.

Cause:

The rubber compounder did not have the internal capability to formulate to FDA standards. Additionally, it did not have a separate white production line. Having experienced contamination problems in the past, the stopper manufacturer knew that separate capacity was critical to avoid carbon black contamination of the new lighter grey and red products.

Download the case study to learn how switching to Action Technology’s customized rubber sheet, a stopper manufacturer was able to realize multiple benefits.

Download the Case Study

Have a question? Contact us today!

Your Name*
First Last
Your Company*
Your Phone
Your Email*
Your geographic region?*
Primary area(s) of interest:
Your Message
Consent*
- I consent to digital communications from TPI.
I consent to receive digital communications (including email and social media posts) from Tekni-Plex, Inc. and its direct and indirect subsidiaries (“Tekni-Plex”). I understand that I may revoke this consent and/or or opt-out of receiving communications from Tekni-Plex at any time by using the unsubscribe link provided in Tekni-Plex’s email communications or by choosing to unfollow Tekni-Plex on social media.